Experimental group:Antiretroviral therapy+HANK cell therapy

2 trials

Sponsors

Tianjin Second People Hospital, Tianjin Second People's Hospital

Conditions

AIDS

Unknown Phase

A Study for Highly Activated NK Cells in the Immunotherapy of Good Viral Suppression AIDS Patients with Poor Immune Rebuilding

Active, not recruitingChiCTR1900020634

Tianjin Second People HospitalAIDS

Start: 2017-11-24Updated: 2019-01-14

Study for Cytotoxicity and Immunoregulatory Function of Highly Actived NK Cells in the Treatment of AIDS

RecruitingChiCTR1900021196

Tianjin Second People's HospitalAIDS

Start: 2019-02-01Updated: 2019-02-04

Related Papers

Safety and efficacy of allogeneic natural killer cell immunotherapy on human immunodeficiency virus type 1 immunological non-responders: a brief report

Chinese Medical Journal2020-11-044 citations